Viewing Study NCT07270666

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:23 PM
Ignite Modification Date: 2026-02-03 @ 6:21 AM
Study NCT ID: NCT07270666
Status: RECRUITING
Last Update Posted: 2025-12-18
First Post: 2025-11-26
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Endometrial Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Stage III with residual disease View
None Stage IV View
None Recurrent endometrial cancer after adjuvant therapy only View
None ctDNA Testing View
None 25-337 View